Roche to Offer Flu Pill in U.S. for Just $50 — Bypassing Channels
Swiss pharma giant Roche is launching direct-to-consumer U.S. sales of its influenza treatment Xofluza priced at $50 per course, a steep 70% discount on its list price. The offering — available to both insured and uninsured patients — will be sold via same-day delivery services like Alto Pharmacy, Amazon Pharmacy, and Mark Cuban’s Cost Plus…